BenUeberrothMD
Internal Medicine • Aurora, COMedical student with career interests in medical oncology, clinical research, translational medicine and medical education.
Dr. Ueberroth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12801 E 17th Ave
Ste 8117
Aurora, CO 80045Phone+1 303-724-9238
Summary
- Medical student with career interests in medical oncology, clinical research, translational medicine and medical education.
Education & Training
Mayo Clinic College of Medicine and Science (Scottsdale)Residency, Internal Medicine, 2019 - 2022
Wayne State University School of MedicineClass of 2019
Barrett, the Honors College at Arizona State UniversityBachelor of Science, Biochemistry (Medicinal Chemistry), Magna cum laude, 2009 - 2013- Barrett, the Honors College at Arizona State UniversityBachelor of Science, Biological Sciences (Genetics, Cell & Developmental Biology), Magna cum laude, 2009 - 2013
Certifications & Licensure
AZ State Medical License 2020 - 2025
CO State Medical License 2023 - 2025
MN State Medical License 2021 - 2022- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Medical Student Summer Research Fellowship Wayne State University School of Medicine, 2016
- All Saints Clinic Grant DMC Foundation, 2016
Publications & Presentations
PubMed
- 6 citationsThe impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, Ellen Jaeger, Elisa Ledet
The Prostate. 2022-09-01 - 7 citationsMulticancer Early detection Panels (MCEDs) in the Primary Care Setting.Benjamin E Ueberroth, Lisa A Marks, Mitesh J Borad, Neera Agrwal
The American Journal of Medicine. 2022-07-01 - 8 citationsCirculating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma.Benjamin E Ueberroth, Jeremy C Jones, Tanios S Bekaii-Saab
Pancreatology. 2022-09-01
Professional Memberships
- American College of PhysiciansMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
